(Q57373962)

English

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination

article

In more languages

Statements

scholarly article

0 references

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination (English)

0 references

0 references

0 references

Marco Ballestri

object named as

Marco Ballestri

8

0 references

object named as

Luisa Tondelli

9

0 references

Katia Sparnacci

object named as

Katia Sparnacci

7

0 references

Antonella Caputo

object named as

Antonella Caputo

13

0 references

object named as

Michele Laus

6

0 references

Riccardo Gavioli

object named as

Riccardo Gavioli

11

0 references

object named as

Barbara Ensoli

12

0 references

Egidio Brocca-Cofano

2

object named as

Egidio Brocca-Cofano

0 references

Arianna Castaldello

1

object named as

Arianna Castaldello

0 references

3

object named as

Rebecca Voltan

0 references

4

object named as

Chiara Triulzi

0 references

author name string

Giuseppe Altavilla

5

0 references

Cinzia Fortini

10

0 references

language of work or name

0 references

publication date

July 2006

0 references

0 references

24

0 references

29-30

0 references

5655-5669

0 references

DNA vaccines: a key for inducing long-term cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

DNA vaccines: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Non-viral vector as vaccine carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Microparticles for the delivery of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Strategies for DNA vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Genetic immunization using nanoparticles engineered from microemulsion precursors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Topical immunization using nanoengineered genetic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Recent advances in vaccine adjuvants for systemic and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Recent developments in vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Charged polylactide co-glycolide microparticles as antigen delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Recent advances in the development of HIV-1 Tat-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Core-shell functional nanospheres for oligonucleotide delivery. III. Stealth nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Expression and characterization of the trans-activator of HTLV-III/LAV virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

based on heuristic

inferred from DOI database lookup

High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.058

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.05.058

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57373962&oldid=1833579014"